CliniGA CRO

CliniGA CRO Blog

SSCP consistency: align the public summary with clinical evidence

A summary of safety and clinical performance should remain readable and consistent with the evidence supporting the device.

Cover image for: SSCP consistency: align the public summary with clinical evidence
Photo: U.S. Navy photo by Seaman Dagan Alexander · License: Public domain · Cropped and resized.
Published
Updated
Sources checked

A summary of safety and clinical performance should remain readable and consistent with the evidence supporting the device.

SSCP consistency — Define the regulatory scope

MDR Article 32 defines the applicable SSCP requirement for implantable and class III devices, with specified exclusions. MDCG SSCP guidance supports structure and presentation.

SSCP consistency — Build the working record

Build a crosscheck between intended purpose, residual risks, alternatives, PMCF findings, instructions for use and clinical evaluation. Identify audiences and the applicable validation and publication workflow without presenting the summary as advertising.

SSCP consistency — Check before release

  • Match the device and certificate scope.
  • Compare benefit and residual risk language.
  • Track revisions across the underlying documents.

SSCP consistency — Record the decision and handover

Resolve differences with clinical, regulatory and labelling owners. Retain the validation and release evidence applicable to the device and check the current EUDAMED arrangements before updating the public record.

Frequently asked questions

Does every medical device need an SSCP?
No. Determine whether Article 32 applies, including its exclusions.
Can the SSCP promise better outcomes than the CER?
No. Public claims must remain supported and consistent with the clinical evaluation.

Sources

  1. Primary requirement: MDR Article 32: SSCP
  2. Operational guidance: MDCG 2019-9 rev.1: SSCP